Additional Information
Book Details
Abstract
Featuring new photos and new treatment options, Pediatric Dermatology DDx Deck, 2nd Edition is a quick-reference, highly portable way to keep up with the rapidly changing field of pediatric dermatology.
- Unique format allows you to quickly access clinical photos, descriptions, history, physical findings, and treatments for more than 150 conditions.
- Arranged according to skin appearance, helping you find the most relevant condition more quickly.
- Cross references (DDx-refs) enable you to quickly view other potential diagnoses.
- An ideal, pocket-sized guide to diagnosis of children of all ages, including newborns.
- More than 560 full-color photographs depict virtually any pediatric skin condition you’re likely to see.
- New content shows primary and secondary lesions.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Pediatric Dermatology DDX Deck | i | ||
Table Of Contents | ii | ||
Primary and secondary lesions | 1 | ||
Primary lesions | 2 | ||
Secondary changes | 2 | ||
Color | 4 | ||
Arrangement | 4 | ||
Distribution | 4 | ||
Hair and nails | 4 | ||
Use of the DDx Deck | 4 | ||
1 Blisters (vesicles and bullae) | 5 | ||
1 Herpes simplex infections | 5 | ||
Clinical Features | 6 | ||
Primary gingivostomatitis | 6 | ||
Recurrent herpes simplex infection | 8 | ||
Herpes labialis | 8 | ||
Herpes keratitis | 8 | ||
Herpes facialis | 8 | ||
Herpetic whitlow | 10 | ||
Herpes progenitalis | 10 | ||
Herpes simplex in the immunosuppressed | 10 | ||
Eczema herpeticum (Kaposi’s varicelliform eruption) | 10 | ||
Treatment | 10 | ||
Oral acyclovir, famciclovir, or valacyclovir | 10 | ||
Herpes keratitis | 10 | ||
2 Varicella and herpes zoster | 11 | ||
Clinical Features | 12 | ||
Varicella | 12 | ||
Childhood varicella | 12 | ||
Secondary bacterial infection | 12 | ||
Varicella vaccines | 12 | ||
Herpes zoster | 14 | ||
Zoster | 14 | ||
Treatment | 14 | ||
In the healthy child | 14 | ||
Secondary bullous impetigo | 14 | ||
Post-varicella scarring | 14 | ||
3 Hand, foot, and mouth disease | 15 | ||
Clinical Features | 16 | ||
This acral condition | 16 | ||
Atypical hand, foot, and mouth syndrome | 16 | ||
Treatment | 16 | ||
4 Sucking blisters | 15 | ||
5 Impetigo and ecthyma | 17 | ||
Clinical Features | 18 | ||
Moist, honey-colored crusts | 18 | ||
Staphylococcus aureus and streptococcus | 18 | ||
Ecthyma | 18 | ||
Treatment | 18 | ||
Topical antibiotics | 18 | ||
As MRSA remains a concern | 18 | ||
6 Staphylococcal scalded skin syndrome (SSSS) | 19 | ||
Clinical Features | 20 | ||
In infants and toddlers | 20 | ||
SSSS is the result of a bacterial toxin | 20 | ||
The toxin | 20 | ||
Treatment | 20 | ||
Infants and toddlers | 20 | ||
7 Miliaria | 21 | ||
2 Mucosal erosions (blister bases) | 39 | ||
19 Aphthous ulcers | 39 | ||
Clinical Features | 40 | ||
Recurrences | 40 | ||
Large ulcers | 40 | ||
Treatment | 40 | ||
Mild attacks | 40 | ||
Topical steroids | 40 | ||
For major aphthae | 40 | ||
20 Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) | 41 | ||
Clinical Features | 42 | ||
SJS | 42 | ||
TEN | 42 | ||
Reported mortality rates | 42 | ||
Treatment | 42 | ||
Admission to a burn unit | 42 | ||
Ophthalmologic care | 42 | ||
21 Geographic tongue | 43 | ||
3 Pustular lesions | 45 | ||
23 Folliculitis | 45 | ||
4 Red papules and nodules | 55 | ||
28 Furunculosis and cellulitis | 55 | ||
Clinical Features | 56 | ||
Furunculosis | 56 | ||
5 Flat vascular lesions, blanching | 81 | ||
45 Mottling | 81 | ||
6 Raised blanching vascular lesions | 101 | ||
55 Hemangiomas | 101 | ||
Clinical Features | 102 | ||
Hemangiomas of infancy (HOI) | 102 | ||
There are three major types | 102 | ||
Deep HOI | 102 | ||
The stationary growth phase | 102 | ||
The regressive phase | 102 | ||
Local complications of HOI | 102 | ||
Infection | 104 | ||
The location of an HOI | 104 | ||
There are two other types of vascular lesions | 104 | ||
RICH | 104 | ||
NICH | 104 | ||
Treatment | 104 | ||
Small ulcerations | 106 | ||
For larger ulcerations | 106 | ||
Superficial HOI | 106 | ||
Magnetic resonance imaging | 106 | ||
Infants with PHACE syndrome | 106 | ||
For other HOI | 106 | ||
RICH & NICH | 106 | ||
56 Diffuse neonatal hemangiomatosis | 107 | ||
57 Pyogenic granuloma | 107 | ||
Clinical Features | 108 | ||
Treatment | 108 | ||
58 Lymphatic malformations | 109 | ||
Clinical Features | 110 | ||
Lymphatic malformations | 110 | ||
7 Non-blanching vascular lesions (petechiae and purpura) | 115 | ||
61 Vasculitis (Henoch–Schönlein purpura) | 115 | ||
8 Papulosquamous eruptions | 123 | ||
66 Pityriasis rosea | 123 | ||
Clinical Features | 124 | ||
Pityriasis rosea (PR) | 124 | ||
The ‘herald’ patch | 124 | ||
Children with a nontruncal distribution | 124 | ||
Treatment | 124 | ||
Most children and teens | 124 | ||
67 Psoriasis | 125 | ||
Clinical Features | 126 | ||
Psoriasis | 126 | ||
In childhood | 126 | ||
Genital involvement | 126 | ||
A subtype of psoriasis | 126 | ||
Children | 126 | ||
The isomorphic phenomenon | 126 | ||
The psoriatic lesions | 126 | ||
9 Eczematous disorders (red with disruption of skin surface) | 159 | ||
79 Atopic dermatitis (AD) | 159 | ||
Clinical Features | 160 | ||
Atopic dermatitis | 160 | ||
A shiny skin surface and prominent skin lines | 162 | ||
Deep scratching | 162 | ||
Chronic mild inflammation | 162 | ||
Herpes simplex | 162 | ||
Sweating | 162 | ||
Irritating substances | 162 | ||
Stress and anxiety | 162 | ||
Treatment | 162 | ||
For red itchy skin | 162 | ||
Lichenified skin | 162 | ||
Topical pimecrolimus cream | 164 | ||
Relief of itching | 164 | ||
Wet dressings | 164 | ||
Antimicrobial Treatments | 164 | ||
For bacterial infections | 164 | ||
Severe disease | 164 | ||
80 Allergic contact dermatitis (ACD) | 165 | ||
Clinical Features | 166 | ||
In acute blistering ACD | 166 | ||
Most Prevalent Allergens in Childhood | 166 | ||
Plants | 166 | ||
Metals | 166 | ||
Neomycin and/or bacitracin | 166 | ||
Potassium dichromate | 166 | ||
Thimerosal | 166 | ||
Balsam of peru | 166 | ||
Formaldehyde, quaterniumn-15 | 166 | ||
Lanolin | 166 | ||
Treatment | 168 | ||
With greater body involvement | 168 | ||
For acute blistering ACD | 168 | ||
Allergen avoidance | 168 | ||
81 Diaper dermatitis | 169 | ||
Clinical Features | 170 | ||
A rash limited to skin under the diaper | 170 | ||
The third form | 170 | ||
The final form | 170 | ||
Langerhans cell histiocytosis | 170 | ||
Diaper dermatitis | 170 | ||
Treatment | 170 | ||
Changing the diaper frequently | 170 | ||
Restricting fluid intake at night just prior to sleep | 170 | ||
Any diaper rash | 170 | ||
82 Intertrigo | 171 | ||
Clinical Features | 172 | ||
Both bacteria and yeast | 172 | ||
The chubby baby, or overweight child, or the child who has hands or feet in water for a prolonged time | 172 | ||
Treatment | 172 | ||
For bacterial intertrigo | 172 | ||
For C. albicans | 172 | ||
83 Candidiasis | 173 | ||
Clinical Features | 174 | ||
In macerated skin, | 174 | ||
In the immunosuppressed or immunodeficient child, | 174 | ||
Congenital candidiasis, | 174 | ||
Vulvovaginal candidiasis | 174 | ||
Candidal granulomas | 174 | ||
Children with HIV infection, | 174 | ||
Treatment | 174 | ||
For infantile thrush, | 174 | ||
Older children | 174 | ||
84 Perianal cellulitis | 175 | ||
10 Skin-colored papules and nodules with a rough surface | 185 | ||
91 Warts | 185 | ||
Clinical Features | 186 | ||
Common warts | 186 | ||
Filiform warts | 186 | ||
Mucosal warts | 186 | ||
Flat warts | 186 | ||
Plantar warts | 186 | ||
Venereal warts | 186 | ||
Treatment | 188 | ||
Wart therapy | 188 | ||
Filiform warts | 188 | ||
Plantar warts | 188 | ||
Cotton plasters | 188 | ||
Salicylic acid | 188 | ||
Vascular selective lasers | 190 | ||
Strong cytodestructive therapies | 190 | ||
Vesicants | 190 | ||
Immunologic therapies. | 190 | ||
Vaccines. | 190 | ||
Antiproliferative treatments | 190 | ||
Psychotherapy | 190 | ||
92 Epidermal nevi (ILVEN) | 191 | ||
11 Skin-colored papules and nodules with a smooth surface | 193 | ||
94 Molluscum contagiosum | 193 | ||
Clinical Features | 194 | ||
In the child with atopic dermatitis, | 194 | ||
In immune suppressed children or those with HIV infection, | 194 | ||
MCV 1 | 194 | ||
Treatment | 194 | ||
50% of molluscum will resolve within 1 year | 194 | ||
If many mollusca are present, | 194 | ||
New mollusca | 194 | ||
Pustular mollusca | 194 | ||
95 Milia and sebaceous hyperplasia | 195 | ||
Clinical Features | 196 | ||
Sebaceous hyperplasia | 196 | ||
Treatment | 196 | ||
In the older child, | 196 | ||
96 Epidermal cysts | 197 | ||
Clinical Features | 198 | ||
12 White lesions | 209 | ||
104 Post-inflammatory hypopigmentation and pityriasis alba | 209 | ||
Clinical Features | 210 | ||
Post-inflammatory hypopigmentation | 210 | ||
Pityriasis alba | 210 | ||
In both conditions, | 210 | ||
Treatment | 210 | ||
105 Vitiligo | 211 | ||
Clinical Features | 212 | ||
Vitiligo | 212 | ||
In dark-skinned children | 212 | ||
Generalized vitiligo | 212 | ||
Segmental vitiligo | 212 | ||
Treatment | 212 | ||
In children with minimal disease | 212 | ||
For children with <20% of the body surface involved | 212 | ||
If >25% of the body surface is involved | 212 | ||
In chronic vitiligo, | 212 | ||
106 Piebaldism | 213 | ||
13 Flat brown lesions | 225 | ||
116 Mongolian spots | 225 | ||
14 Raised brown lesions | 237 | ||
128 Congenital melanocytic nevi | 237 | ||
Clinical Features | 238 | ||
Newer classifications | 238 | ||
SCMN | 238 | ||
LCMN | 238 | ||
Numerous smaller nevi | 238 | ||
Neurocutaneous melanosis (NCM) | 238 | ||
Treatment | 238 | ||
129 Intradermal melanocytic nevi | 239 | ||
Clinical Features | 240 | ||
Atypical melanocytic nevi | 240 | ||
Blue nevi | 242 | ||
Spitz nevi (spindle and epithelioid nevi) | 242 | ||
Treatment | 242 | ||
130 Mastocytosis | 243 | ||
Clinical Features | 244 | ||
15 Yellow lesions | 249 | ||
135 Nevus sebaceous | 249 | ||
16 Congenital circumscribed hair loss | 253 | ||
139 Aplasia cutis congenita | 253 | ||
Clinical Features | 254 | ||
Syndromic aplasia cutis | 254 | ||
Scalp sebaceous nevi | 254 | ||
Treatment | 254 | ||
17 Acquired circumscribed hair loss | 255 | ||
140 Alopecia areata (AA) | 255 | ||
Clinical Features | 256 | ||
Examination of the nails | 256 | ||
Alopecia areata | 256 | ||
Treatment | 256 | ||
141 Tinea capitis and kerion | 257 | ||
Clinical Features | 258 | ||
In T. tonsurans infection, | 258 | ||
In M. canis infections, | 258 | ||
There are four inflammatory stages: | 258 | ||
Kerions | 258 | ||
Family members | 258 | ||
Treatment | 258 | ||
Oral griseofulvin | 258 | ||
Oral fluconazole and itraconazole | 258 | ||
Sharing of hats, | 258 | ||
142 Traction alopecia and hair pulling | 259 | ||
Clinical Features | 260 | ||
Traction alopecia | 260 | ||
Acute hair pulling | 260 | ||
Trichotillomania | 260 | ||
Treatment | 260 | ||
18 Congenital diffuse hair loss | 261 | ||
143 Ectodermal dysplasias (ED) | 261 | ||
19 Acquired diffuse hair loss | 263 | ||
145 Telogen and anagen effluvium | 263 | ||
Clinical Features | 264 | ||
Treatment | 264 | ||
20 Thickened nails | 265 | ||
146 Pachyonychia congenita (PC) | 265 | ||
147 Ectodermal dysplasia (nails) | 265 | ||
Clinical Features | 266 | ||
Treatment | 266 | ||
148 Median nail dystrophy | 267 | ||
21 Thin, slow-growing, or loss of nail | 271 | ||
152 Ectodermal dysplasia and nail-patella syndrome | 271 | ||
Clinical Features | 272 | ||
Treatment | 272 | ||
22 Pitted lesions | 273 | ||
153 Ear pits and lip pits | 273 | ||
23 Involvement of palms and soles | 275 | ||
155 Palmoplantar keratodermas | 275 | ||
Clinical Features | 276 | ||
Treatment | 276 | ||
24 Photodistribution (sun-induced lesions) | 277 | ||
156 Polymorphous light eruption | 277 | ||
25 Annular arrangements | 279 | ||
158 Annular arrangement | 279 | ||
Clinical Features | 280 | ||
The herald patch of pityriasis rosea | 280 | ||
Large urticaria | 280 | ||
External skin injuries | 280 | ||
26 Linear or curvilinear arrangements | 281 | ||
159 Linear or curvilinear arrangement | 281 | ||
Copyright Page | IBC1 | ||
A Guide to Topical Steroids in Children | IBC2 |